Bulletin
Investor Alert

Rubius Therapeutics Inc.

NAS: RUBY

GO
/marketstate/country/us

After Hours

/zigman2/quotes/204835982/composite

$

5.51

Change

0.00 0.00%

Volume

Volume 10,017

Sep 18, 2020, 5:55 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/204835982/composite

Previous close

$ 5.11

$ 5.51

Change

+0.40 +7.83%

Day low

Day high

$5.08

$5.57

Open
Open: 5.19

52 week low

52 week high

$3.35

$14.44

Open

Market cap

$445.03M

Average volume

170,930

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-2.23

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/ruby

MarketWatch News on RUBY

  1. Rubius Therapeutics downgraded to neutral from overweight at J.P. Morgan

    8:54 a.m. Jan. 31, 2020

    - Tomi Kilgore

  2. Rubius Therapeutics stock price target cut to $22 vs. $27 at JPMorgan

    8:42 a.m. Aug. 29, 2019

    - Ciara Linnane

  3. Rubius Therapeutics started at overweight with $37 stock price target at Morgan Stanley

    9:46 a.m. Aug. 13, 2018

    - Tomi Kilgore

  4. Rubius Therapeutics started at overweight with $28 stock price target at J.P. Morgan

    7:40 a.m. Aug. 13, 2018

    - Tomi Kilgore

  5. Rubius Therapeutics started at outperform with $30 stock price target at Leerink

    7:04 a.m. Aug. 13, 2018

    - Tomi Kilgore

  6. Rubius Therapeutics shares surge 35% in trading debut

    11:02 a.m. July 18, 2018

    - Ciara Linnane

  7. Rubius Therapeutics shares surge 35% in trading debut

    10:59 a.m. July 18, 2018

    - Ciara Linnane

  8. Rubius Therapeutics prices IPO at $23 a share

    10:11 p.m. July 17, 2018

    - Sue Chang

/news/nonmarketwatch/company/us/ruby

Other News on RUBY

  1. Rubius Therapeutics (RUBY) Investor Presentation - Slideshow

    7:20 p.m. Sept. 17, 2020

    - Seeking Alpha

  2. 10-Q: RUBIUS THERAPEUTICS, INC.

    8:24 a.m. Aug. 10, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  3. IPO Update: Generation Bio Proposes IPO Terms

    3:31 p.m. June 9, 2020

    - Seeking Alpha

  4. Rubius Therapeutics (RUBY) Investor Presentation - Slideshow

    2:52 p.m. May 11, 2020

    - Seeking Alpha

  5. 10-Q: RUBIUS THERAPEUTICS, INC.

    8:23 a.m. May 11, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  6. BioMarin (BMRN) Beats on Q1 Earnings, Lowers Sales View

    9:47 a.m. April 30, 2020

    - Zacks.com

  7. Daily Insider Ratings Round Up 4/24/20

    1:01 p.m. April 27, 2020

    - Seeking Alpha

  8. Baird bearish on Rubius Therapeutics - sees 29% downside

    1:49 p.m. March 23, 2020

    - Seeking Alpha

  9. Goldman sees 143% upside in Amarin in premarket analyst action

    7:26 a.m. March 13, 2020

    - Seeking Alpha

  10. TUP, ZAGG, MCRB and BLFS among midday movers

    12:43 p.m. March 12, 2020

    - Seeking Alpha

  11. 10-K: RUBIUS THERAPEUTICS, INC.

    9:04 a.m. March 12, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  12. Rubius launches early-stage study of lead drug in PKU

    1:30 p.m. Jan. 30, 2020

    - Seeking Alpha

  13. Loading more headlines...
/news/pressrelease/company/us/ruby

Press Releases on RUBY

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.